SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001358403-15-000093
Filing Date
2015-11-09
Accepted
2015-11-09 16:11:17
Documents
10
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a2015q310qbellicum.htm 10-Q 686829
2 EXHIBIT 31.1 a2015q3exh311.htm EX-31.1 12239
3 EXHIBIT 31.2 a2015q3exh312.htm EX-31.2 12402
4 EXHIBIT 32.0 a2015q3exh32.htm EX-32.0 11385
  Complete submission text file 0001358403-15-000093.txt   3309134

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT blcm-20150930.xml EX-101.INS 557793
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT blcm-20150930.xsd EX-101.SCH 30090
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT blcm-20150930_cal.xml EX-101.CAL 51221
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT blcm-20150930_def.xml EX-101.DEF 89380
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT blcm-20150930_lab.xml EX-101.LAB 403015
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT blcm-20150930_pre.xml EX-101.PRE 204346
Mailing Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030
Business Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030 (832) 384-1100
BELLICUM PHARMACEUTICALS, INC (Filer) CIK: 0001358403 (see all company filings)

IRS No.: 201450200 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36783 | Film No.: 151215712
SIC: 2834 Pharmaceutical Preparations